What contract structure lowers entry cost for laboratories digitising the Anatomic Pathology Market workflow?

Reagent-rental and pay-per-slide agreements shift scanners and stainers off the capital budget entirely. Vendors recover cost through contracted consumable volume over five to seven years [19]. Read More

How should buyers evaluate interoperability before signing a digital pathology contract?

Insist on DICOM-conformant image export and documented LIS integration in the specification, not the sales deck. Proprietary formats make future vendor migration prohibitively expensive [15]. Read More

Do AI tools create new liability exposure for pathologists in the Anatomic Pathology Market?

Signing pathologists retain diagnostic responsibility regardless of algorithmic input. Laboratories should document override rates and maintain version logs for every deployed model [11]. Read More

What validation work does a laboratory owe before digital primary diagnosis?

Professional guidance recommends a concordance study across at least 60 cases per subspecialty, with a washout interval between glass and digital reads [5]. Read More

Which procurement mistake most often derails Anatomic Pathology Market digitisation projects?

Underbudgeting storage. Scanned slides at high magnification consume gigabytes each, and multi-year retention obligations frequently exceed the original scanner spend [3]. Read More

How does IVDR affect laboratories operating outside the European Union?

Any laboratory supplying assays into EU member states falls within scope, and multinational reference networks must appoint an authorised representative and meet conformity requirements [14]. Read More

Where does spatial biology sit on the clinical adoption curve today?

Predominantly translational and trial-facing rather than routine. Reimbursement precedent for immunotherapy selection is the trigger that would move it into standard panels [8]. Read More

Anatomic Pathology Market (2026 - 2035)

ID: MRFR/HC/1779-HCR 200 Pages Satyendra Maurya Last Updated: September 15, 2026

Anatomic Pathology Market Research Report: Size, Share, Trend Analysis By Types of Pathology (Histopathology, Cytopathology, Molecular Pathology, Forensic Pathology), By Technology (Digital Pathology, Traditional Pathology, Immunohistochemistry, In situ Hybridization), By Applications (Cancer Diagnosis, Infectious Disease Diagnosis, Genetic Testing, Tissue Banking), By End Users (Hospitals, Diagnostic Laboratories, Research Institutes) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035

Anatomic Pathology Market

Market Size

Forecast Period2026-2035

CAGR (2026-2035)8.19%

2025 Market SizeUSD 41.02 Billion

2035 Market SizeUSD 89.70 Billion

Key Players

F. Hoffmann-La Roche

Danaher

Thermo Fisher Scientific

Agilent Technologies

Becton Dickinson

Sakura Finetek

Trends

Cancer Burden Growth Sets the Volume Floor
Digital Workflows Convert Capital into Throughput
Pharmaceutical Partnerships Create a Second Revenue Layer

Opportunities

AI Triage as a Reimbursable Service Line
Emerging-Market Laboratory Build-Out
Real-World Tissue Data Monetisation

Summary Table of Contents Segmentation Methodology Download PDF

1 Market Summary |
1. 1.1 Study Assumptions & Market Definition |
2. 1.2 Scope of the Study |
3. 1.3 Research Methodology
2 Key Report Takeaways |
1. 2.1 By Product & Services |
2. 2.2 By Application & End User |
3. 2.3 By Geography
3 Market Size & Forecast (2021–2035) |
1. 3.1 Historical Market Size (2021–2025) |
2. 3.2 Current & Forecast Market Size (2026–2035) |
3. 3.3 Market Size by Revenue (USD Billion) |
4. 3.4 Year-over-Year Growth Analysis
4 Driver Impact Analysis |
1. 4.1 Cancer Burden Growth Sets the Volume Floor |
2. 4.2 Digital Workflows Convert Capital into Throughput |
3. 4.3 Pharmaceutical Partnerships Create a Second Revenue Layer
5 Restraints Impact Analysis |
1. 5.1 The Workforce Gap Is the Binding Constraint |
2. 5.2 Capital Barriers Slow Digital Adoption Outside Wealthy Systems |
3. 5.3 Regulatory Cost Reshapes the Assay Landscape
6 Opportunities |
1. 6.1 AI Triage as a Reimbursable Service Line |
2. 6.2 Emerging-Market Laboratory Build-Out |
3. 6.3 Real-World Tissue Data Monetisation |
4. 6.4 Spatial and Multiplex Assays Entering Routine Panels |
5. 6.5 Subspecialty Teleconsultation Networks
7 Regional Market Share & Country-Level Analysis |
1. 7.1 North America | |
  1. 7.1.1 US | |
  2. 7.1.2 Canada | |
  3. 7.1.3 Mexico |
2. 7.2 Europe | |
  1. 7.2.1 Germany | |
  2. 7.2.2 UK | |
  3. 7.2.3 France | |
  4. 7.2.4 Italy | |
  5. 7.2.5 Spain | |
  6. 7.2.6 Nordic Countries | |
  7. 7.2.7 Russia | |
  8. 7.2.8 Rest of Europe |
3. 7.3 Asia-Pacific | |
  1. 7.3.1 China | |
  2. 7.3.2 India | |
  3. 7.3.3 Japan | |
  4. 7.3.4 South Korea | |
  5. 7.3.5 ASEAN | |
  6. 7.3.6 Rest of Asia-Pacific |
4. 7.4 South America | |
  1. 7.4.1 Brazil | |
  2. 7.4.2 Argentina | |
  3. 7.4.3 Rest of South America |
5. 7.5 Middle East & Africa | |
  1. 7.5.1 Saudi Arabia | |
  2. 7.5.2 UAE | |
  3. 7.5.3 South Africa | |
  4. 7.5.4 Egypt | |
  5. 7.5.5 Rest of Middle East & Africa
8 Future Outlook (2026–2035) |
1. 8.1 Algorithms Move from Adjunct to Default |
2. 8.2 Platform Economics Reshape Vendor Relationships |
3. 8.3 Precision Oncology Deepens Tissue Demand |
4. 8.4 Sustainability and Reagent Stewardship
9 Market Segmentation Analysis |
1. 9.1 By Product & Services | |
  1. 9.1.1 Instruments | |
  2. 9.1.2 Consumables | |
  3. 9.1.3 Services |
2. 9.2 By Application | |
  1. 9.2.1 Disease Diagnosis | |
  2. 9.2.2 Drug Discovery & Development | |
  3. 9.2.3 Other Applications |
3. 9.3 By End User | |
  1. 9.3.1 Hospitals | |
  2. 9.3.2 Diagnostic Laboratories | |
  3. 9.3.3 Research & Academic Institutes | |
  4. 9.3.4 Other End Users
10 Competitive Landscape |
1. 10.1 Market Concentration Analysis (2026) |
2. 10.2 Competitive Benchmarking Matrix |
3. 10.3 Company Profiles | |
  1. 10.3.1 F. Hoffmann-La Roche (Ventana) | |
  2. 10.3.2 Danaher (Leica Biosystems) | |
  3. 10.3.3 Thermo Fisher Scientific | |
  4. 10.3.4 Agilent Technologies (Dako) | |
  5. 10.3.5 Becton Dickinson | |
  6. 10.3.6 Sakura Finetek | |
  7. 10.3.7 Hologic | |
  8. 10.3.8 PHC Holdings (Epredia) | |
  9. 10.3.9 Bio-Rad Laboratories | |
  10. 10.3.10 Merck KGaA | |
  11. 10.3.11 Koninklijke Philips | |
  12. 10.3.12 BioGenex Laboratories
11 Recent News & Developments
12 Report Scope & Methodology |
1. 12.1 Study Period & Base Year |
2. 12.2 Valuation Currency & Conversion Basis |
3. 12.3 Abbreviations
13 Detailed Sources & Citations
14 Frequently Asked Questions
15 LIST OF TABLES |
TABLE 1 Global Anatomic Pathology Market Size & Forecast, by Revenue (USD Billion), 2021–2035 |
TABLE 2 Global Anatomic Pathology Market – Year-over-Year Growth Analysis, 2021–2035 |
TABLE 3 Driver Impact Analysis Matrix, 2026–2035 |
TABLE 4 Restraint Impact Analysis Matrix, 2026–2035 |
TABLE 5 Global Anatomic Pathology Market Size, by Region, 2021–2035 (USD Billion) |
TABLE 6 North America Anatomic Pathology Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 7 Europe Anatomic Pathology Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 8 Asia-Pacific Anatomic Pathology Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 9 South America Anatomic Pathology Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 10 Middle East & Africa Anatomic Pathology Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 11 Global Anatomic Pathology Market Size, by Product & Services, 2021–2035 (USD Billion) |
TABLE 12 Global Anatomic Pathology Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 13 Global Anatomic Pathology Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 14 North America Anatomic Pathology Market Size, by Product & Services, 2021–2035 (USD Billion) |
TABLE 15 North America Anatomic Pathology Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 16 North America Anatomic Pathology Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 17 Europe Anatomic Pathology Market Size, by Product & Services, 2021–2035 (USD Billion) |
TABLE 18 Europe Anatomic Pathology Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 19 Europe Anatomic Pathology Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 20 Asia-Pacific Anatomic Pathology Market Size, by Product & Services, 2021–2035 (USD Billion) |
TABLE 21 Asia-Pacific Anatomic Pathology Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 22 Asia-Pacific Anatomic Pathology Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 23 South America Anatomic Pathology Market Size, by Product & Services, 2021–2035 (USD Billion) |
TABLE 24 South America Anatomic Pathology Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 25 South America Anatomic Pathology Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 26 Middle East & Africa Anatomic Pathology Market Size, by Product & Services, 2021–2035 (USD Billion) |
TABLE 27 Middle East & Africa Anatomic Pathology Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 28 Middle East & Africa Anatomic Pathology Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 29 US Anatomic Pathology Market Size, by Product & Services, 2021–2035 (USD Billion) |
TABLE 30 US Anatomic Pathology Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 31 US Anatomic Pathology Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 32 Germany Anatomic Pathology Market Size, by Product & Services, 2021–2035 (USD Billion) |
TABLE 33 Germany Anatomic Pathology Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 34 China Anatomic Pathology Market Size, by Product & Services, 2021–2035 (USD Billion) |
TABLE 35 China Anatomic Pathology Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 36 India Anatomic Pathology Market Size, by Product & Services, 2021–2035 (USD Billion) |
TABLE 37 India Anatomic Pathology Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 38 Japan Anatomic Pathology Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 39 Brazil Anatomic Pathology Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 40 Saudi Arabia Anatomic Pathology Market Size, by Product & Services, 2021–2035 (USD Billion) |
TABLE 41 Competitive Benchmarking Matrix – Anatomic Pathology Market, 2026 |
TABLE 42 Company Profiles – Key Players, Anatomic Pathology Market |
TABLE 43 Recent Developments & Strategic Announcements, 2023–2025 |
TABLE 44 Report Scope & Methodology Summary |
TABLE 45 Detailed Sources & Citations Index
16 LIST OF FIGURES |
FIGURE 1 Anatomic Pathology Market Dynamics – Drivers, Restraints, Opportunities and Challenges |
FIGURE 2 Industry Value Chain Analysis – Anatomic Pathology Market |
FIGURE 3 Porter's Five Forces Analysis – Anatomic Pathology Market |
FIGURE 4 Global Market Size Trend & Forecast, 2021–2035 (USD Billion) |
FIGURE 5 Year-over-Year Growth Trajectory, 2022–2035 (%) |
FIGURE 6 Driver Impact Contribution to Forecast CAGR (pp) |
FIGURE 7 Restraint Impact Drag on Forecast CAGR (pp) |
FIGURE 8 Market Share by Product & Services, 2025 vs 2035 (%) |
FIGURE 9 Market Share by Application, 2025 vs 2035 (%) |
FIGURE 10 Market Share by End User, 2025 vs 2035 (%) |
FIGURE 11 Regional Revenue Share Distribution, 2025 (%) |
FIGURE 12 Regional Revenue Share Distribution, 2035 (%) |
FIGURE 13 Regional CAGR Comparison, 2026–2035 (%) |
FIGURE 14 North America Country-Level Share Breakdown, 2025 (%) |
FIGURE 15 Europe Country-Level Share Breakdown, 2025 (%) |
FIGURE 16 Asia-Pacific Country-Level Share Breakdown, 2025 (%) |
FIGURE 17 South America and Middle East & Africa Country Share Breakdown, 2025 (%) |
FIGURE 18 Competitive Landscape – Estimated Revenue Share Bands, 2026 (%) |
FIGURE 19 Competitive Positioning Matrix – Portfolio Breadth vs Digital Capability |
FIGURE 20 Digital Pathology Adoption Curve by Region, 2021–2035

Certified Researchers

Enquiry

Customize Report

Segmentation Quick Reference

Dimension	Sub-Segments	Dominant Segment	Fastest Growing Segment
By Product & Services	Instruments; Consumables; Services	Consumables	Services
By Application	Disease Diagnosis; Drug Discovery & Development; Other Applications	Disease Diagnosis	Drug Discovery & Development
By End User	Hospitals; Diagnostic Laboratories; Research & Academic Institutes; Other End Users	Hospitals	Diagnostic Laboratories
By Geography	North America; Europe; Asia-Pacific; South America; Middle East & Africa	North America	Asia-Pacific

Market Segmentation Overview

By Product & Services

Sub-Segment	Key Trend
Instruments	Scanner and autostainer refresh cycles tied to digital conversion capital approvals
Consumables	Antibody menu expansion and multiplex detection kits lifting spend per case
Services	Managed subspecialty reads and cloud archive contracts converting fixed cost to variable

Recurring consumable spend remains the financial engine of this dimension, while services grow fastest as laboratories rent expertise they cannot hire. Instrument demand is lumpier, rising and falling with hospital capital cycles and grant awards.

By Application

Sub-Segment	Key Trend
Disease Diagnosis	Screening programme expansion and earlier-stage detection lifting slide volumes
Drug Discovery & Development	Companion diagnostic co-development contracts tied to biomarker-defined approvals
Other Applications	Academic, forensic, and veterinary tissue work expanding on grant and private funding

Diagnosis supplies the volume; drug development supplies the margin. Sponsor-funded tissue programmes are also structurally insulated from public health budget cycles, which is why suppliers actively court them.

By End User

Sub-Segment	Key Trend
Hospitals	Tumour board turnaround requirements favouring in-house histology retention
Diagnostic Laboratories	Hub-and-spoke consolidation absorbing volume hospitals cannot staff
Research & Academic Institutes	Translational tissue atlas programmes and biobank-linked studies
Other End Users	Contract research organisations and public health reference laboratories

Volume is migrating from hospital benches to independent networks wherever staffing pressure bites hardest. Academic centres set the protocols that both groups eventually adopt, giving them influence far beyond their revenue share.

By Geography

Sub-Segment	Key Trend
North America	Reimbursement-led consolidation and early digital primary diagnosis adoption
Europe	IVDR compliance reshaping assay portfolios and favouring large reference networks
Asia-Pacific	Greenfield laboratory construction skipping the analogue equipment generation
South America	Public-private partnership models extending oncology diagnostic access
Middle East & Africa	Sovereign health investment funding fully digital flagship laboratories

Mature regions grow through value per case; emerging regions grow through new capacity. That distinction determines which commercial model — premium platform sales versus reagent-rental placement — wins in each geography.

Certified Researchers

Enquiry

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”

Guilherme Gomes Martins Product Management Director

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”